1269x588px_CS_Orphan-Drug-Designation
5 March 2018
Pharmablue
Did you like this article? Share on social networks:
5 March 2018
Pharmablue
Did you like this article? Share on social networks:
Rare diseases: At the core of our mission At PharmaBlue, we’ve spent the past decade...
Known as Expanded Access Programs in the US, early access programs (EAP) allow access to...
Expanded Access is a treatment option that allows the use of an unauthorized medicine (investigational...